The link between endometriosis and ovarian cancer clinical implications

Farr Reza Nezhat, Tanja Pejovic, Fernando M. Reis, Sun Wei Guo

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Objectives: The objectives of this study were to evaluate the current evidence of the association of endometriosis and subsequent carcinoma of the ovary and to contextualize this evidence into daily practice issues. Methods: This study is a critical review of observational and in vitro studies. Results: Although the lifetime risk for ovarian cancer is low in general population and remains low in the broad spectrum of endometriosis, there may be clusters of individuals at higher risk of oncogenesis, whose identification would allow individualized surveillance and prophylactic interventions. Prevalence studies show that specific subtypes of ovarian cancer predominate in women with endometriosis. This has been validated in pathogenetic, genomic, immunobiologic, and hormonal studies. Conclusions: Taken together, these data provide a strong rationale for identifying, monitoring, counseling, and treating women with endometriosis who are at highest risk for cancer conversion.

Original languageEnglish (US)
Pages (from-to)623-628
Number of pages6
JournalInternational Journal of Gynecological Cancer
Volume24
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Endometriosis
Ovarian Neoplasms
Counseling
Ovary
Carcinogenesis
Cross-Sectional Studies
Carcinoma
Population
Neoplasms

Keywords

  • Clinical implications
  • Endometriosis
  • Ovarian carcinoma subtype

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology
  • Medicine(all)

Cite this

The link between endometriosis and ovarian cancer clinical implications. / Nezhat, Farr Reza; Pejovic, Tanja; Reis, Fernando M.; Guo, Sun Wei.

In: International Journal of Gynecological Cancer, Vol. 24, No. 4, 2014, p. 623-628.

Research output: Contribution to journalArticle

Nezhat, Farr Reza ; Pejovic, Tanja ; Reis, Fernando M. ; Guo, Sun Wei. / The link between endometriosis and ovarian cancer clinical implications. In: International Journal of Gynecological Cancer. 2014 ; Vol. 24, No. 4. pp. 623-628.
@article{bf69af4d6e1c41f796721fef27794230,
title = "The link between endometriosis and ovarian cancer clinical implications",
abstract = "Objectives: The objectives of this study were to evaluate the current evidence of the association of endometriosis and subsequent carcinoma of the ovary and to contextualize this evidence into daily practice issues. Methods: This study is a critical review of observational and in vitro studies. Results: Although the lifetime risk for ovarian cancer is low in general population and remains low in the broad spectrum of endometriosis, there may be clusters of individuals at higher risk of oncogenesis, whose identification would allow individualized surveillance and prophylactic interventions. Prevalence studies show that specific subtypes of ovarian cancer predominate in women with endometriosis. This has been validated in pathogenetic, genomic, immunobiologic, and hormonal studies. Conclusions: Taken together, these data provide a strong rationale for identifying, monitoring, counseling, and treating women with endometriosis who are at highest risk for cancer conversion.",
keywords = "Clinical implications, Endometriosis, Ovarian carcinoma subtype",
author = "Nezhat, {Farr Reza} and Tanja Pejovic and Reis, {Fernando M.} and Guo, {Sun Wei}",
year = "2014",
doi = "10.1097/IGC.0000000000000100",
language = "English (US)",
volume = "24",
pages = "623--628",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The link between endometriosis and ovarian cancer clinical implications

AU - Nezhat, Farr Reza

AU - Pejovic, Tanja

AU - Reis, Fernando M.

AU - Guo, Sun Wei

PY - 2014

Y1 - 2014

N2 - Objectives: The objectives of this study were to evaluate the current evidence of the association of endometriosis and subsequent carcinoma of the ovary and to contextualize this evidence into daily practice issues. Methods: This study is a critical review of observational and in vitro studies. Results: Although the lifetime risk for ovarian cancer is low in general population and remains low in the broad spectrum of endometriosis, there may be clusters of individuals at higher risk of oncogenesis, whose identification would allow individualized surveillance and prophylactic interventions. Prevalence studies show that specific subtypes of ovarian cancer predominate in women with endometriosis. This has been validated in pathogenetic, genomic, immunobiologic, and hormonal studies. Conclusions: Taken together, these data provide a strong rationale for identifying, monitoring, counseling, and treating women with endometriosis who are at highest risk for cancer conversion.

AB - Objectives: The objectives of this study were to evaluate the current evidence of the association of endometriosis and subsequent carcinoma of the ovary and to contextualize this evidence into daily practice issues. Methods: This study is a critical review of observational and in vitro studies. Results: Although the lifetime risk for ovarian cancer is low in general population and remains low in the broad spectrum of endometriosis, there may be clusters of individuals at higher risk of oncogenesis, whose identification would allow individualized surveillance and prophylactic interventions. Prevalence studies show that specific subtypes of ovarian cancer predominate in women with endometriosis. This has been validated in pathogenetic, genomic, immunobiologic, and hormonal studies. Conclusions: Taken together, these data provide a strong rationale for identifying, monitoring, counseling, and treating women with endometriosis who are at highest risk for cancer conversion.

KW - Clinical implications

KW - Endometriosis

KW - Ovarian carcinoma subtype

UR - http://www.scopus.com/inward/record.url?scp=84900412386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900412386&partnerID=8YFLogxK

U2 - 10.1097/IGC.0000000000000100

DO - 10.1097/IGC.0000000000000100

M3 - Article

VL - 24

SP - 623

EP - 628

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 4

ER -